Osteoporosis and skeletal dysplasia caused by pathogenic variants in SGMS2

Show full item record



Permalink

http://hdl.handle.net/10138/301402

Citation

Pekkinen , M , Terhal , P A , Botto , L D , Henning , P , Mäkitie , R E , Roschger , P , Jain , A , Kol , M , Kjellberg , M A , Paschalis , E P , van Gassen , K , Murray , M , Bayrak-Toydemir , P , Magnusson , M K , Jans , J , Kausar , M , Carey , J C , Somerharju , P , Lerner , U H , Olkkonen , V M , Klaushofer , K , Holthuis , J C M & Mäkitie , O 2019 , ' Osteoporosis and skeletal dysplasia caused by pathogenic variants in SGMS2 ' , JCI INSIGHT , vol. 4 , no. 7 , 126180 . https://doi.org/10.1172/jci.insight.126180

Title: Osteoporosis and skeletal dysplasia caused by pathogenic variants in SGMS2
Author: Pekkinen, Minna; Terhal, Paulien A.; Botto, Lorenzo D.; Henning, Petra; Mäkitie, Riikka E.; Roschger, Paul; Jain, Amrita; Kol, Matthijs; Kjellberg, Matti A.; Paschalis, Eleftherios P.; van Gassen, Koen; Murray, Mary; Bayrak-Toydemir, Pinar; Magnusson, Maria K.; Jans, Judith; Kausar, Mehran; Carey, John C.; Somerharju, Pentti; Lerner, Ulf H.; Olkkonen, Vesa M.; Klaushofer, Klaus; Holthuis, Joost C. M.; Mäkitie, Outi
Contributor: University of Helsinki, Clinicum
University of Helsinki, Children's Hospital
University of Helsinki, VERIFIN
University of Helsinki, Medicum
University of Helsinki, Medicum
University of Helsinki, Lastentautien yksikkö
Date: 2019-04-04
Language: eng
Number of pages: 20
Belongs to series: JCI INSIGHT
ISSN: 2379-3708
URI: http://hdl.handle.net/10138/301402
Abstract: Mechanisms leading to osteoporosis are incompletely understood. Genetic disorders with skeletal fragility provide insight into metabolic pathways contributing to bone strength. We evaluated 6 families with rare skeletal phenotypes and osteoporosis by next-generation sequencing. In all the families, we identified a heterozygous variant in SGMS2, a gene prominently expressed in cortical bone and encoding the plasma membrane-resident sphingomyelin synthase SMS2. Four unrelated families shared the same nonsense variant, c.148C>T (p.Arg50*), whereas the other families had a missense variant, c.185T>G (p.IIe62Ser) or c.191T>G (p.Met64Arg). Subjects with p.Arg50* presented with childhood-onset osteoporosis with or without cranial sclerosis. Patients with p.IIe62Ser or p.Met64Arg had a more severe presentation, with neonatal fractures, severe short stature, and spondylometaphyseal dysplasial Several subjects had experienced peripheral facial nerve palsy or other neurological manifestations. Bone biopsies showed markedly altered bone material characteristics, including defective bone mineralization. Osteoclast formation and function in vitro was normal. While the p.Arg50* mutation yielded a catalytically inactive enzyme, p.IIe62Ser and p.Met64Arg each enhanced the rate of de novo sphingomyelin production by blocking export of a functional enzyme from the endoplasmic reticulum. SGMS2 pathogenic variants underlie a spectrum of skeletal conditions, ranging from isolated osteoporosis to complex skeletal dysplasia, suggesting a critical role for plasma membrane-bound sphingomyelin metabolism in skeletal homeostasis.
Subject: MINERALIZATION DENSITY DISTRIBUTION
CALVARIAL DOUGHNUT LESIONS
RELATIVE QUANTIFICATION
NORMATIVE DATA
SPHINGOMYELIN
OSTEOGENESIS
METABOLISM
MUTATIONS
SPHINGOSINE-1-PHOSPHATE
OSTEOPETROSIS
3111 Biomedicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
jci.insight.126180.v2.pdf 1.404Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record